tirzepatide super obesity bmi 60 Morbid Obesity: Chart, Health Risks, Weight Loss Medscape | A new scoring

If we truly care about public health, we should stop asking whether patients are allowed to need long-term obesity treatment and start asking why we have not built a health care system that reliably provides it

As demand for GLP-1s has grown, so has a gray market fueled by deceptive advertising and unregulated products sold as affordable alternatives. These are not real alternatives they are unsafe shortcuts

Each session typically lasts 3060 minutes and is customized to your recovery or wellness goals

Start with lower doses to assess tolerance, gradually increasing as appropriate

Beyond appetite control, it has metabolic benefits such as improving insulin sensitivity, reducing excessive insulin levels, and aiding in fat utilization

The right choice depends on what you value most